NDC 58607-112

Myferon 150 Forte

Iron Sucrose, Folic Acid, Cyanocobalamin

Myferon 150 Forte is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Martin Ekwealor Pharmaceuticals, Inc.. The primary component is Iron Sucrose; Folic Acid; Cyanocobalamin.

Product ID58607-112_24af9e28-be37-44a7-89c9-629f29b621e9
NDC58607-112
Product TypeHuman Prescription Drug
Proprietary NameMyferon 150 Forte
Generic NameIron Sucrose, Folic Acid, Cyanocobalamin
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date1996-12-01
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameMARTIN EKWEALOR PHARMACEUTICALS, INC.
Substance NameIRON SUCROSE; FOLIC ACID; CYANOCOBALAMIN
Active Ingredient Strength150 mg/1; mg/1; ug/1
Pharm ClassesIron [CS],Parenteral Iron Replacement [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA],Vitamin B 12 [CS],Vitamin B12 [EPC]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 58607-112-00

100 BLISTER PACK in 1 BOX (58607-112-00) > 10 CAPSULE in 1 BLISTER PACK
Marketing Start Date1996-12-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 58607-112-00 [58607011200]

Myferon 150 Forte CAPSULE
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1996-12-01
Inactivation Date2019-11-27

Drug Details

Active Ingredients

IngredientStrength
IRON SUCROSE150 mg/1

OpenFDA Data

SPL SET ID:ed2308e3-5310-41bd-9333-615c26183493
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 309606
  • Pharmacological Class

    • Iron [CS]
    • Parenteral Iron Replacement [EPC]
    • Phosphate Binder [EPC]
    • Phosphate Chelating Activity [MoA]
    • Vitamin B 12 [CS]
    • Vitamin B12 [EPC]

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.